Phesi

Phesi is an AI-powered clinical data science company that helps biopharmaceutical and life sciences organizations accelerate drug development and commercialization. By leveraging the world's largest clinical trials database — encompassing data from over 325 million patients, 485,000 curated clinical trials, 4.2 million physicians, and more than 4,000 disease indications — Phesi delivers precision insights that enable smarter, faster, and more cost-effective clinical trials across all phases of development and therapeutic areas, including rare diseases.

Phesi's integrated analytical products and services cover the entire clinical development process, from development planning and indication assessment through protocol evaluation, site selection, and trial implementation management. Trusted by leading pharmaceutical companies including Sanofi and Takeda, Phesi partners with trial sponsors to remove barriers to effective clinical trials and get novel therapies to patients faster and at reduced cost.

Trial Accelerator™ Platform

• The core operating system through which Phesi delivers its integrated suite of patient-centric analytics
• Structured into four sequential views: Patient View, Trial Performance View, Country Performance View, and Investigator Site View
• Patient View — provides a data-driven understanding of the relevant global patient population
• Trial Performance View — simulates key performance outcomes such as enrollment cycle time and optimum investigator site numbers
• Country Performance View — identifies the highest-performing countries for trial execution
• Investigator Site View — ranks KOL and investigator performance to support optimal site selection
• Powered by Phesi's proprietary integrated methodology and patented AI technologies
• Enables predictive modelling tailored to client needs, from protocol design through to site selection

Digital Patient Profile

• Provides a detailed, accurate picture of potential trial participants using a diverse set of real-world data sources
• Captures key demographic and clinical details including age, gender, and health conditions
• Guides researchers in identifying and recruiting the right patients for any clinical trial
• Ensures trial designs are precisely aligned with the characteristics of the target patient population
• Supports improved patient population accuracy and diversity across all indications

Protocol Design Optimization

• Uses modal design value simulation to eliminate costly trial failures and protocol amendments
• Applies systematic analysis of clinical trial, protocol, and site data to form evidence-based hypotheses about trial design
• Helps sponsors refine existing trial designs and pioneer new approaches with confidence
• Demonstrated to deliver significantly quicker and more cost-effective development timelines on priority assets

Digital Twin and External Control Arm Services

• Models diseases and patient outcomes using Digital Patient Profiles and real-world data
• Generates Digital Twins and Digital Trial Arms to produce reliable clinical evidence without the time and expense of traditional trial arms
• Supports adaptive trial design evaluation to identify the best-performing trial configurations
• Reduces patient burden while maintaining the integrity and quality of clinical evidence

Data Assets and Platform Capabilities

• World's largest clinical trials database containing dynamically updated real-world data
• Over 325 million patients profiled across more than 4,000 disease indications
• 485,000 curated clinical trials and data from 4.2 million physicians
• 100,000 updated data sources continuously integrated into the platform
• Proprietary AI platform automates analysis throughout program, protocol, and trial design, recruitment, and management processes

Recognition and Customer Validation

• Winner of the 2025 Clinical Trials Arena Excellence Award for Innovation
• Recognized with a leading position on Frost & Sullivan's Frost Radar™ for AI-enabled clinical trials
• Endorsed by senior clinical operations leaders at Takeda and former SVP and Global Chief Medical Officer at Sanofi
• Ongoing research publications covering global clinical trial trends, including disease study patterns and geopolitical impacts on trial activity

Phesi's patient-first philosophy underpins every aspect of its platform and services, ensuring that clinical trials are designed with precision, insight, and certainty. By integrating patient and trial data at scale and applying proven AI-driven methodologies, Phesi empowers life sciences companies to navigate the complexities of clinical development with confidence and deliver breakthrough therapies to patients faster.